ArticleNPJ precision oncology2025

Quantitative profiling of intratumor immune heterogeneity identifies loss of immune diversity as a hallmark of cancer progression.

Qiqi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.